🚨 New insights from the Lancet! 🚑

In the OPTION–STEMI trial, immediate multivessel PCI during the index procedure failed to show non-inferiority compared to staged revascularisation in STEMI patients with multivessel disease.

🧠 Key takeaway? Timing matters.

⚠️ Higher risk in those with heart failure (Killip II/III)

💡 Safer strategy: staged PCI for high-risk patients

📊 Fractional flow reserve, procedural MI, and guideline implications all in focus.

A must-read for interventionalists & clinical guideline leaders.

🔗 https://doi.org/10.1016/S0140-6736(25)01529-6

#STEMI #PCI #InterventionalCardiology #Lancet #CardioTwitter #Revascularisation #KillipClass #FFR #ClinicalTrials #Cardiology ❤️🫀